Application of microPET imaging approaches in the study of pediatric anesthetic-induced neuronal toxicity

Journal of Applied Toxicology

Volumn 33, Issue 9, 2013, Pages 861-868

  Zhang, Xuan ^a   Paule, Merle G ^a   Wang, Cheng ^a   Slikker, William ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

Anesthetic agent; Molecular imaging; Neuronal cell death

Indexed keywords

3' FLUOROTHYMIDINE; 3' FLUOROTHYMIDINE F 18; 5 (DIMETHYLAMINO) N' ( 4 FLUOROBENZYLIDENE)NAPHTHALENE 1 SULFONOHYDRAZIDE; ANESTHETIC AGENT; CARBON 11; FLUORINE 18; FLUORODEOXYGLUCOSE F 18; GALLIUM 68; GLUCOSE; IODINE 124; IODINE 125; ISOFLURANE; KETAMINE; LIPOCORTIN 5; N [ 2 ( 2 FLUOROETHOXY)BENZYL] N ( 4 PHENOXYPYRIDIN 3 YL)ACETAMIDE F 18; NAPHTHALENESULFONIC ACID DERIVATIVE; NITROGEN 13; NITROUS OXIDE; OXYGEN; OXYGEN 15; PHOSPHOLIPID; PROPOFOL; RADIOISOTOPE; SODIUM CHLORIDE; TECHNETIUM 99M; TRACER; UNCLASSIFIED DRUG;

ANESTHESIA; APOPTOSIS; ASTROCYTE; BRAIN; BRAIN DEVELOPMENT; CELL DAMAGE; CELL MEMBRANE; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM; GENERAL ANESTHESIA; GLUCOSE METABOLISM; HUMAN; IN VITRO STUDY; IN VIVO STUDY; ISOTOPE LABELING; MACROPHAGE; MICRO POSITRON EMISSION TOMOGRAPHY; MICROGLIA; MOLECULAR IMAGING; NERVE CELL; NEUROIMAGING; NEUROTOXICITY; NON INVASIVE PROCEDURE; NONHUMAN; PEDIATRICS; PET SCANNER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOACTIVITY; REVIEW; RODENT; SYNAPTOGENESIS;

ANIMALIA;

EID: 84880823219     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.2857     Document Type: Review

References (87)

1. Aloya R, Shirvan A, Grimberg H, Reshef A, Levin G, Kidron D, Cohen A, Ziv I. 2006 Molecular imaging of cell death in vivo by a novel small molecule probe. Apoptosis 11: 2089-2101.
2. Allen RT, Hunter WJ, Agrawal DK. 1997 Morphological and biochemical characterization and analysis of apoptosis. J. Pharmacol. Toxicol. Methods 37: 215-228.
3. Bading JR, Shields AF. 2008 Imaging of cell proliferation: status and prospects. J. Nucl. Med. 49(Suppl 2): 64S-80S.
4. Banati RB. 2003 Neuropathological imaging: in vivo detection of glial activation as a measure of disease and adaptive change in the brain. Br. Med. Bull. 65: 121-131.
5. Benavides J, Fage D, Carter C, Scatton B. 1987 Peripheral type benzodiazepine binding sites are a sensitive indirect index of neuronal damage. Brain Res. 421: 167-172.
6. Bennacef I, Salinas C, Horvath G, Gunn R, Bonasera T, Wilson AA, Laruelle M. 2008. Comparison of [11C]PBR28 and [18F]FEPPA as CNS peripheral benzodiazepine receptor PET ligands in the pig. J. Nucl. Med. 49: 81.
7. Berridge MS, Apana SM, Hersh JM. 2009. Teflon radiolysis as the major source of carrier in fluorine-18. J. Labelled Compd. Rad. 52: 543-548.
8. Bianchi SL, Tran T, Liu C, Lin S, Li Y, Keller JM, Eckenhoff RG, Eckenhoff MF. 2008. Brain and behavior changes in 12-month-old Tg2576 and nontransgenic mice exposed to anesthetics. Neurobiol. Aging 29: 1002-1010.
9. Bouman NH, Koot HM, Hazebroek FW. 1999. Long-term physical, psychological, and social functioning of children with esophageal atresia. J. Pediatr. Surg. 34: 399-404.
10. Braestrup C, Albrechtsen R, Squires RF. 1977. High densities of benzodiazepine receptors in human cortical areas. Nature 269: 702-704.
11. Briard E, Zoghbi SS, Imaizumi M, Gourley JP, Shetty HU, Hong J, Cropley V, Fujita M, Innis RB, Pike VW. 2008. Synthesis and evaluation in monkey of two sensitive 11C-labeled aryloxyanilide ligands for imaging brain peripheral benzodiazepine receptors in vivo. J. Med. Chem. 51: 17-30.
12. Campbell LL, Tyson JA, Stackpole EE, Hokenson KE, Sherrill H, McKeon JE, Kim SA, Edmands SD, Suarez C, Hall AC. 2011. Assessment of general anaesthetic cytotoxicity in murine cortical neurones in dissociated culture. Toxicology 283: 1-7.
13. Chacko J, Ford WD, Haslam R. 1999. Growth and neurodevelopmental outcome in extremely-low-birth-weight infants after laparotomy. Pediatr. Surg. Int. 15: 496-499.
14. Chatziioannou AF. 2002. Molecular imaging of small animals with dedicated PET tomographs. Eur. J. Nucl. Med. Mol. Imaging 29: 98-114.
15. Chen YY, Shih YY, Chien CN, Chou TW, Lee TW, Jaw FS. 2009. MicroPET study of brain neuronal metabolism under electrical and mechanical stimulation of the rat tail. Nucl. Med. Commun. 30: 188-193.
16. Cohen A, Shirvan A, Levin G, Grimberg H, Reshef A, Ziv I. 2009. From the Gla domain to a novel small-molecule detector of apoptosis. Cell Res. 19: 625-637.
17. D'Arceuil H, Rhine W, de Crespigny A, Yenari M, Tait JF, Strauss WH, Engelhorn, T, Kastrup A, Moseley M, Blankenberg FG. 2000. 99mTc annexin V imaging of neonatal hypoxic brain injury. Stroke 31: 2692-2700.
18. Franks NP, Lieb WR. 1994. Molecular and cellular mechanisms of general anaesthesia. Nature 367: 607-614.
19. Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL, Henson PM. 1992. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers recognition and removal by macrophages. J. Immunol. 148: 2207-2216.
20. Grierson JR, Yagle KJ, Eary JF, Tait JF, Gibson DF, Lewellen B, Link JM, Krohn KA. 2004. Production of [F-18] fluoroannexin for imaging apoptosis with PET. Bioconjugate. Chem. 15: 373-379.
21. Hardwick M, Fertikh D, Culty M, Li H, Vidic B, Papadopoulos V. 1999. Peripheral-type benzodiazepine receptor (PBR) in human breast cancer: correlation of breast cancer cell aggressive phenotype with PBR expression, nuclear localization, and PBR-mediated cell proliferation and nuclear transport of cholesterol. Cancer Res. 59: 831-842.
22. Hayashi H, Dikkes P, Soriano SG. 2002. Repeated administration of ketamine may lead to neuronal degeneration in the developing rat brain. Paediatr. Anaesth. 12: 770-774.
23. Hume SP, Myers R. 2002. Dedicated small animal scanners: a new tool for drug development? Curr. Pharm. Des. 8: 1497-1511.
24. Hutchins GD, Miller MA, Soon VC, Receveur T. 2008. Small animal PET imaging. ILAR J. 49: 54-65.
25. Ikonomidou C, Bittigau P, Koch C, Genz K, Hoerster F, Felderhoff-Mueser U, Tenkova T, Dikranian K, Olney JW. 2001. Neurotransmitters and apoptosis in the developing brain. Biochem. Pharmacol. 62: 401-405.
26. Ikonomidou C, Bosch F, Miksa M, Bittigau P, Vockler J, Dikranian K, Tenkova TI, Stefovska V, Turski L, Olney JW. 1999. Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science 283: 70-74.
27. Imaizumi M, Briard E, Zoghbi SS, Gourley JP, Hong J, Fujimura Y, Pike VW, Innis RB, Fujita M. 2008. Brain and whole-body imaging in nonhuman primates of [11C]PBR28, a promising PET radioligand for peripheral benzodiazepine receptors. Neuroimage 39: 1289-1298.
28. Ito F, Toyama H, Kudo G, Suzuki H, Hatano K, Ichise M, Katada K, Ito K, Sawada M. 2010. Two activated stages of microglia and PET imaging of peripheral benzodiazepine receptors with [(11)C]PK11195 in rats. Ann. Nucl. Med. 24: 163-169.
29. Jacobs AH, Rueger MA, Winkeler A, Li H, Vollmar S, Waerzeggers Y, Rueckriem B, Kummer C, Dittmar C, Klein M, Heneka MT, Herrlinger U, Fraefel C, Graf R, Wienhard K, Heiss WD. 2007. Imaging-guided gene therapy of experimental gliomas. Cancer Res. 67: 1706-1715.
30. Jevtovic-Todorovic V, Hartman RE, Izumi Y, Benshoff ND, Dikranian K, Zorumski CF, Olney JW, Wozniak DF. 2003. Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits. J. Neurosci. 23: 876-882.
31. Kabra NS, Schmidt B, Roberts RS, Doyle LW, Papile L, Fanaroff A. 2007. Neurosensory impairment after surgical closure of patent ductus arteriosus in extremely low birth weight infants: results from the Trial of Indomethacin Prophylaxis in Preterms. J. Pediatr. 150: 229-234, 234 e221.
32. Kohrs R, Durieux ME. 1998. Ketamine: teaching an old drug new tricks. Anesth. Analg. 87: 1186-1193.
33. Kuhlmann AC, Guilarte TR. 1999. Regional and temporal expression of the peripheral benzodiazepine receptor in MPTP neurotoxicity. Toxicol. Sci. 48: 107-116.
34. Kuhlmann AC, Guilarte TR. 2000. Cellular and subcellular localization of peripheral benzodiazepine receptors after trimethyltin neurotoxicity. J. Neurochem. 74: 1694-1704.
35. Lahorte CM, Vanderheyden JL, Steinmetz N, Van de Wiele C. Dierckx RA, Slegers G. 2004. Apoptosis-detecting radioligands: current state of the art and future perspectives. Eur. J. Nucl. Med. Mol. Imaging 31: 887-919.
36. Lancelot S, Zimmer L. 2010. Small-animal positron emission tomography as a tool for neuropharmacology. Trends Pharmacol. Sci. 31: 411-417.
37. Lang S. 2002. The role of peripheral benzodiazepine receptors (PBRs) in CNS pathophysiology. Curr. Med. Chem. 9: 1411-1415.
38. Lorberboym M, Blankenberg FG, Sadeh M, Lampl Y. 2006. In vivo imaging of apoptosis in patients with acute stroke: correlation with blood-brain barrier permeability. Brain Res. 1103: 13-19.
39. Ludman L, Spitz L, Wade A. 2001. Educational attainments in early adolescence of infants who required major neonatal surgery. J. Pediatr. Surg. 36: 858-862.
40. Luker GD, Sharma V, Piwnica-Worms D. 2003. Visualizing protein-protein interactions in living animals. Methods 29: 110-122.
41. Mellon RD, Simone AF, Rappaport BA. 2007. Use of anesthetic agents in neonates and young children. Anesth. Analg. 104: 509-520.
42. Myers R. 2001. The biological application of small animal PET imaging. Nucl. Med. Biol. 28: 585-593.
43. Myers R, Hume S. 2002. Small animal PET. Eur. Neuropsychopharmacol. 12: 545-555.
44. Oke BO, Suarez-Quian CA, Riond J, Ferrara P, Papadopoulos V. 1992. Cell surface localization of the peripheral-type benzodiazepine receptor (PBR) in adrenal cortex. Mol. Cell. Endocrinol. 87: R1-R6.
45. Ohashi K, Ichikawa K, Chen L, Callahan M, Zasadny K, Kurebayashi Y. 2008. MicroPET detection of regional brain activation induced by colonic distention in a rat model of visceral hypersensitivity. J. Vet. Med. Sci. 70: 43-49.
46. Oku N, Kashiwagi T, Hatazawa J. 2010. Nuclear neuroimaging in acute and subacute ischemic stroke. Ann. Nucl. Med. 24: 629-638.
47. Olney JW, Wozniak DF, Jevtovic-Todorovic V, Farber NB, Bittigau P, Ikonomidou C. 2002. Drug-induced apoptotic neurodegeneration in the developing brain. Brain Pathol. 12: 488-498.
48. Olson JM, Ciliax BJ, Mancini WR, Young AB. 1988. Presence of peripheral-type benzodiazepine binding sites on human erythrocyte membranes. Eur. J. Pharmacol. 152: 47-53.
49. Papadopoulos V, Baraldi M, Guilarte TR, Knudsen TB, Lacapere JJ, Lindemann P, Norenberg MD, Nutt D, Weizman A, Zhang MR, Gavish M. 2006a. Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol. Sci. 27: 402-409.
50. Papadopoulos V, Lecanu L, Brown RC, Han Z, Yao ZX. 2006b. Peripheral-type benzodiazepine receptor in neurosteroid biosynthesis, neuropathology and neurological disorders. Neuroscience 138: 749-756.
51. Paul AK, Lobarinas E, Simmons R, Wack D, Luisi JC, Spernyak J, Mazurchuk R, Abdel-Nabi H, Salvi R. 2009. Metabolic imaging of rat brain during pharmacologically-induced tinnitus. Neuroimage 44: 312-318.
52. Phelps ME. 2000. Positron emission tomography provides molecular imaging of biological processes. Proc. Natl. Acad. Sci. U. S. A. 97: 9226-9233.
53. Pogge A, Slikker W Jr. 2004. Neuroimaging: new approaches for neurotoxicology. Neurotoxicology 25: 525-531.
54. Reshef A, Shirvan A, Akselrod-Ballin A, Wall A, Ziv I. 2010. Small-molecule biomarkers for clinical PET imaging of apoptosis. J. Nucl. Med. 51: 837-840.
55. Rueger MA, Backes H, Walberer M, Neumaier B, Ullrich R, Simard ML, Emig B, Fink GR, Hoehn M, Graf R, Schroeter M. 2010. Noninvasive imaging of endogenous neural stem cell mobilization in vivo using positron emission tomography. J. Neurosci. 30: 6454-6460.
56. Rusjan PM, Wilson AA, Bloomfield PM, Vitcu I, Meyer JH, Houle S, Mizrahi R. 2011. Quantitation of translocator protein binding in human brain with the novel radioligand [(18)F]-FEPPA and positron emission tomography. J. Cereb. Blood Flow Metab. 31: 1807-1816.
57. Saraste A, Pulkki K. 2000. Morphologic and biochemical hallmarks of apoptosis. Cardiovasc. Res. 45: 528-537.
58. Scallet AC, Schmued LC, Slikker W Jr, Grunberg N, Faustino PJ, Davis H, Lester D, Pine PS, Sistare F, Hanig JP. 2004. Developmental neurotoxicity of ketamine: morphometric confirmation, exposure parameters, and multiple fluorescent labeling of apoptotic neurons. Toxicol. Sci. 81: 364-370.
59. Schlegel RA, Williamson P. 2001. Phosphatidylserine, a death knell. Cell Death Differ. 8: 551-563.
60. Schnockel U, Hermann S, Stegger L, Law M, Kuhlmann M, Schober O, Schafers K, Schafers M. 2010. Small-animal PET: a promising, non-invasive tool in pre-clinical research. Eur. J. Pharm. Biopharm. 74: 50-54.
61. Schweitzer PJ, Fallon BA, Mann JJ, Kumar JS. 2010. PET tracers for the peripheral benzodiazepine receptor and uses thereof. Drug Discov. Today 15: 933-942.
62. Shields AF, Grierson JR, Dohmen BM, Machulla HJ, Stayanoff JC, Lawhorn-Crews JM, Obradovich JE, Muzik O, Mangner TJ. 1998. Imaging proliferation in vivo with [F-18]FLT and positron emission tomography. Nat. Med. 4: 1334-1336.
63. Slikker W, Jr., Zou X, Hotchkiss CE, Divine RL, Sadovova N, Twaddle NC, Doerge DR, Scallet AC, Patterson TA, Hanig JP, Paule MG, Wang C. 2007. Ketamine-induced neuronal cell death in the perinatal rhesus monkey. Toxicol. Sci. 98: 145-158.
64. Strauss HW, Blankenberg F, Vanderheyden JL, Tait J. 2008. Translational imaging: imaging of apoptosis. Handb. Exp. Pharmacol. 185: 259-275.
65. Tait JF. 2008. Imaging of apoptosis. J. Nucl. Med. 49: 1573-1576.
66. Takeuchi A, Isobe KI, Miyaishi O, Sawada M, Fan ZH, Nakashima I, Kiuchi K. 1998. Microglial NO induces delayed neuronal death following acute injury in the striatum. Eur. J. Neurosci. 10: 1613-1620.
67. Toretsky J, Levenson A, Weinberg IN, Tait JF, Uren A, Mease RC. 2004. Preparation of F-18 labeled annexin V: a potential PET radiopharmaceutical for imaging cell death. Nucl. Med. Biol. 31: 747-752.
68. Venturini I, Zeneroli ML, Corsi L, Avallone R, Farina F, Alho H, Baraldi C, Ferrarese C, Pecora N, Frigo M, Ardizzone G, Arrigo A, Pellicci R, Baraldi M. 1998. Up-regulation of peripheral benzodiazepine receptor system in hepatocellular carcinoma. Life Sci. 63: 1269-1280.
69. Wagner CC, Langer O. 2011. Approaches using molecular imaging technology -- use of PET in clinical microdose studies. Adv. Drug Deliv. Rev. 63: 539-546.
70. Walker K, Holland AJ, Winlaw D, Sherwood M, Badawi N. 2006. Neurodevelopmental outcomes and surgery in neonates. J. Paediatr. Child Health 42: 749-751.
71. Wang C, Slikker W, Jr. 2008. Strategies and experimental models for evaluating anesthetics: effects on the developing nervous system. Anesth. Analg. 106: 1643-1658.
72. Wang C, Sadovova N, Fu X, Schmued L, Scallet A, Hanig J, Slikker W. 2005. The role of the N-methyl-D-aspartate receptor in ketamine-induced apoptosis in rat forebrain culture. Neuroscience 132: 967-977.
73. Wang S, Peretich K, Zhao Y, Liang G, Meng Q, Wei H. 2009. Anesthesia-induced neurodegeneration in fetal rat brains. Pediatr. Res. 66: 435-440.
74. Wilder RT, Flick RP, Sprung J, Katusic SK, Barbaresi WJ, Mickelson C, Gleich SJ, Schroeder DR, Weaver AL, Warner DO. 2009. Early exposure to anesthesia and learning disabilities in a population-based birth cohort. Anesthesiology 110: 796-804.
75. Wilson AA, Garcia A, Parkes J, McCormick P, Stephenson KA, Houle S, Vasdev N. 2008. Radiosynthesis and initial evaluation of [18F]-FEPPA for PET imaging of peripheral benzodiazepine receptors. Nucl. Med. Biol. 35: 305-314.
76. Wolters SL, Corsten MF, Reutelingsperger CP, Narula J, Hofstra L. 2007. Cardiovascular molecular imaging of apoptosis. Eur. J. Nucl. Med. Mol. Imaging 34(Suppl 1): S86-S98.
77. Xie Z, Dong Y, Maeda U, Moir RD, Xia W, Culley DJ, Crosby G, Tanzi RE. 2007. The inhalation anesthetic isoflurane induces a vicious cycle of apoptosis and amyloid beta-protein accumulation. J. Neurosci. 27: 1247-1254.
78. Yagle KJ, Eary JF, Tait JF, Grierson JR, Link JM, Lewellen B, Gibson DF, Krohn KA. 2005. Evaluation of 18F-annexin V as a PET imaging agent in an animal model of apoptosis. J. Nucl. Med. 46: 658-666.
79. Zeng W, Yao ML, Townsend D, Kabalka G, Wall J, Le Puil M, Biggerstaff J, Miao W. 2008. Synthesis, biological evaluation and radiochemical labeling of a dansylhydrazone derivative as a potential imaging agent for apoptosis. Bioorg. Med. Chem. Lett. 18: 3573-3577.
80. Zhang X, Paule MG, Newport GD, Zou X, Sadovova N, Berridge MS, Apana SM, Hanig JP, Slikker W Jr, Wang C. 2009. A minimally invasive, translational biomarker of ketamine-induced neuronal death in rats: microPET Imaging using 18F-annexin V. Toxicol. Sci. 111: 355-361.
81. Zhang X, Paule MG, Newport GD, Sadovova N, Berridge MS, Apana SM, Kabalka G, Miao W, Slikker W Jr, Wang C. 2011. MicroPET imaging of ketamine-induced neuronal apoptosis with radiolabeled DFNSH. J. Neural Transm. 118: 203-211.
82. Zhang X, Paule MG, Newport GD, Liu F, Callicott R, Liu S, Berridge MS, Apana SM, Slikker W Jr, Wang C. 2012. MicroPET/CT imaging of [18F]-FEPPA in the nonhuman primate: a potential biomarker of pathogenic processes associated with anesthetic-induced neurotoxicity. ISRN Anesthesiol. Article ID 261640, 11 pages.
83. Zijlstra S, Gunawan J, Burchert W. 2003. Synthesis and evaluation of a 18F-labelled recombinant annexin-V derivative, for identification and quantification of apoptotic cells with PET. Appl. Radiat. Isot. 58: 201-207.
84. Zou X, Patterson TA, Divine RL, Sadovova N, Zhang X, Hanig JP, Paule MG, Slikker W, Jr, Wang C. 2009a. Prolonged exposure to ketamine increases neurodegeneration in the developing monkey brain. Int. J. Dev. Neurosci. 27: 727-731.
85. Zou X, Sadovova N, Patterson TA, Divine RL, Hotchkiss CE, Ali SF, Hanig JP, Paule MG, Slikker W Jr, Wang C. 2008. The effects of L-carnitine on the combination of, inhalation anesthetic-induced developmental, neuronal apoptosis in the rat frontal cortex. Neuroscience 151: 1053-1065.
86. Zou X, Liu F, Zhang X, Patterson T, Callicott R, Liu S, Hanig J, Paule M, Slikker W Jr, Wang C. 2011. Inhalation anesthetic-induced neuronal damage in the developing Rhesus monkey. Neurotoxicol. Teratol. 33: 592-527.
87. Zou X, Patterson TA, Sadovova N, Twaddle NC, Doerge DR, Zhang X, Fu X, Hanig JP, Paule MG, Slikker W, Wang C. 2009b. Potential neurotoxicity of ketamine in the developing rat brain. Toxicol. Sci. 108: 149-158.